Learn Before
Relation
Comparing ACE2 and CD147 Expression in Cancer Tissue
Data were obtained from the Gene Expression Profiling Interactive Analysis (GEPIA) based off of The Cancer Genome Atlas (TCGA). Gene expression is reported as transcripts per kilobase million (TPM). Abbreviations used in the figure include:
- ACC. - Adrenocortical carcinoma
- BLCA - Bladder Urothelial Carcinoma
- BRCA - Breast invasive carcinoma
- CESC - Cervical squamous cell carcinoma and endocervical adenocarcinoma
- CHOL - Cholangiocarcinoma
- COAD - Colon adenocarcinoma
- DLBC - Lymphoid Neoplasm Diffuse Large B-cell Lymphom
- ESCA - Esophageal carcinomaGBM - Glioblastoma multiforme
- HNSC - Head and Neck squamous cell carcinoma
- KICH - Kidney Chromophobe
- KIRC - Kidney renal clear cell carcinoma
- KIRP - Kidney renal papillary cell carcinoma
- LAML - Acute Myeloid Leukemia
- LGG - Brain Lower Grade Glioma
- LIHC - Liver hepatocellular carcinoma
- LUAD - Lung adenocarcinoma
- LUSC - Lung squamous cell carcinoma
- OV - Ovarian serous cystadenocarcinoma
- PAAD - Pancreatic adenocarcinoma
- PCPG - Pheochromocytoma and Paraganglioma
- PRAD - Prostate adenocarcinoma
- READ - Rectum adenocarcinoma
- SARC – Sarcoma
- SKCM - Skin Cutaneous Melanoma
- STAD - Stomach adenocarcinoma
- TGCT - Testicular Germ Cell Tumors
- THCA - Thyroid carcinoma
- THYM – Thymoma; UCEC - Uterine Corpus Endometrial Carcinoma
- UCS - Uterine Carcinosarcoma

0
1
Updated 2020-08-07
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
CD147 as a Hypothesized SARS-CoV-2 Receptor
Comparing ACE2 and CD147 Expression in Cancer Tissue
Over-expression of ACE2 in Cancer Tissue
Under-expression of ACE2 in Cancer Tissue
Survival Prognosis of Patients with High/Low ACE2 Expression in Cancer Tissue
Comparing ACE2 and CD147 Expression in Cancer Tissue